New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report

Paradoxical localized exacerbation of psoriatic eruptions triggered by secukinumab

(2018) D. Hoshina et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Paradoxical psoriasis following anti–TNF therapy in ankylosing spondylitis: A population-based cohort study

(2018) Jung Min Bae et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Secukinumab-induced paradoxical pustular psoriasis

(2018) S. Dogra et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Secukinumab-Induced Psoriasiform Eruption

(2017) Michael J. Sladden et al.   JAMA Dermatology

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study

(2016) Jürgen Braun et al.   ANNALS OF THE RHEUMATIC DISEASES

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

(2015) Dominique Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE